IHS Chemical Week

Chemical Week Magazine :: Specialty Chemicals

Wacker biologics acquisition

9:51 AM MST | November 25, 2013

Wacker has announced plans to acquire a production site for bioengineered pharmaceutical proteins, or biologics, from BioNet Ventures. The deal covers Wacker’s acquisition of Scil Proteins Production, including the patent portfolio, at the Scil site at Halle, Germany. The transaction is expected to close early next year. Wacker will continue with existing customer partnerships, which Scil Proteins Production already has, and will retain Scil’s staff. Scil Proteins Production, founded in 2005, has 80 employees and operates a fermenter at Halle, with capacity...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa